marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 09-13-2024
Champions Oncology Balance Sheet 2011-2024 | CSBR
Annual Balance Sheet Champions Oncology
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
4.81 M | -1.52 M | 459 K | 4.91 M | 1.26 M | -3.22 M | -814 K | -3.3 M | -2.58 M | -9.36 M | -5.89 M | -9.56 M | -4.75 M | -10.5 M |
Long Term Debt |
6.09 M | 7.39 M | 8.41 M | 8.78 M | 8.78 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.34 M | 1.21 M | 1.05 M | 818 K | 818 K | 438 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 1 M | 622 K | 164 K | 233 K | 192 K | 2.01 M | 1.05 M | 8.71 M | 9.13 M |
Total Current Liabilities |
21.5 M | 21.7 M | 17.5 M | 11.2 M | 12.1 M | 8.02 M | 7.45 M | 7.45 M | 5.31 M | 3.8 M | 3.66 M | 2.93 M | 3.49 M | - |
Total Liabilities |
28 M | 29.7 M | 26.3 M | 20.2 M | 15.4 M | 9.03 M | 8.08 M | 7.61 M | 5.54 M | 3.99 M | 5.67 M | 3.98 M | 12.2 M | 12.6 M |
Deferred Revenue |
12.1 M | 12.8 M | 11.1 M | 6.26 M | 5.8 M | 4.02 M | 4.7 M | 4.91 M | 3.14 M | 2.01 M | 2.09 M | 1.11 M | 1.18 M | 1.62 M |
Retained Earnings |
-84.6 M | -77.3 M | -72 M | -72.5 M | -72.7 M | -70.7 M | -70.8 M | -69.4 M | -62.5 M | -52 M | -38.9 M | -31.5 M | -25.1 M | -16.5 M |
Total Assets |
26.1 M | 34.3 M | 35.4 M | 27.6 M | 20.8 M | 11.3 M | 8.08 M | 8.01 M | 5.78 M | 12 M | 8.87 M | 11.7 M | 6.92 M | 12.6 M |
Cash and Cash Equivalents |
2.62 M | 10.1 M | 9.01 M | 4.69 M | 8.34 M | 3.24 M | 856 K | 3.3 M | 2.58 M | 9.36 M | 5.89 M | 9.56 M | 4.75 M | 10.5 M |
Book Value |
-1.9 M | 4.64 M | 9.1 M | 7.43 M | 5.32 M | 2.24 M | 3 K | 400 K | 238 K | 8.06 M | 3.2 M | 7.68 M | -5.28 M | 19 K |
Total Shareholders Equity |
-1.9 M | 4.64 M | 9.1 M | 7.43 M | 5.1 M | 2.24 M | 3 K | 400 K | 238 K | 8.06 M | 3.2 M | -9.21 M | -5.28 M | 19 K |
All numbers in USD currency
Quarterly Balance Sheet Champions Oncology
| 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
182 K | 220 K | 6.78 M | 7.11 M | 7.39 M | 8.62 M | 7.83 M | 8.13 M | 8.41 M | 5.8 M | 8.52 M | 8.65 M | 8.78 M | 3.3 M | 5.93 M | 6.04 M | 3.17 M | - | 3.43 M | 3.55 M | 3.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
25.3 M | 28 M | 28.2 M | 28 M | 29.7 M | 24.3 M | 27.2 M | 25.4 M | 26.3 M | 17.2 M | 21.2 M | 20.6 M | 20.2 M | 11.9 M | 18.9 M | 17.3 M | 15.7 M | 8.59 M | 11.8 M | 11.6 M | 9.03 M | 6.62 M | 8.25 M | 7.79 M | 8.08 M | 5.51 M | 6.12 M | 6.18 M | 7.61 M | 4.89 M | 4.84 M | 4.67 M | 5.54 M | 6.98 M | 3.48 M | 3.94 M | 3.99 M | 5.98 M | 5.17 M | 5.24 M | 5.67 M | 3.68 M | 6.36 M | 4.68 M | 3.98 M | 4.09 M | 3.25 M | 2.82 M | 4.04 M | - | 4.1 M | 4.63 M | 4.47 M |
Deferred Revenue |
10.3 M | 12.1 M | 13 M | 11.1 M | 12.8 M | 8.7 M | 11.2 M | 10.9 M | 11.1 M | 6.62 M | 6.13 M | 5.48 M | 6.26 M | 4.59 M | 6.19 M | 5.67 M | 5.82 M | 4.72 M | 4.15 M | 3.97 M | 4.02 M | 3.85 M | 4.83 M | 4.26 M | 4.7 M | 3.62 M | 3.88 M | 3.74 M | 4.91 M | 2.88 M | 3.14 M | 2.7 M | 3.14 M | 2.31 M | 1.64 M | 1.91 M | 2.01 M | 2.1 M | 1.76 M | 1.66 M | 2.09 M | 1.02 M | 1.96 M | 859 K | 1.11 M | 1.5 M | 1.2 M | 918 K | 1.18 M | - | 1.9 M | 2.08 M | 1.62 M |
Retained Earnings |
-83.3 M | -84.6 M | -82 M | -79.9 M | -77.3 M | -71.6 M | -72.3 M | -72.3 M | -72 M | -71.6 M | -72.4 M | -72.7 M | -72.5 M | -70.6 M | -72.6 M | -72.6 M | -72.9 M | -70.4 M | -71 M | -71.3 M | -70.7 M | -70.2 M | -70.1 M | -70.3 M | -70.8 M | -66.9 M | -70.1 M | -70 M | -69.4 M | -59.9 M | -65.5 M | -65 M | -62.5 M | -48.4 M | -57.5 M | -54.9 M | -52 M | -36.6 M | -45.6 M | -42.4 M | -38.9 M | -29.4 M | -36 M | -33.7 M | -31.5 M | -22.6 M | -28.4 M | -26.5 M | -25.1 M | - | -20.9 M | -18.5 M | -16.5 M |
Total Assets |
24.9 M | 26.1 M | 28.3 M | 29.9 M | 34.3 M | 33.6 M | 36.4 M | 34.4 M | 35.4 M | 25.3 M | 29.3 M | 28.1 M | 27.6 M | 15.1 M | 25.8 M | 22.8 M | 20.8 M | 10.9 M | 13.9 M | 13.4 M | 11.3 M | 7.1 M | 10.2 M | 8.39 M | 8.08 M | 7.55 M | 6.49 M | 6.47 M | 8.01 M | 7.14 M | 8.04 M | 7.85 M | 5.78 M | 2.83 M | 7.58 M | 9.85 M | 12 M | 10.5 M | 3.31 M | 5.68 M | 8.87 M | 13 M | 10.5 M | 10.7 M | 11.7 M | 8.86 M | 4.22 M | 5.14 M | 6.92 M | - | 9.87 M | 11.8 M | 12.6 M |
Cash and Cash Equivalents |
2.89 M | 2.62 M | 5.51 M | 4.87 M | 10.1 M | 8.7 M | 10.8 M | 8.06 M | 9.01 M | 7.43 M | 4.78 M | 4 M | 4.69 M | 3.28 M | 8.55 M | 6.94 M | 8.34 M | 3.31 M | 2.78 M | 2.2 M | 3.24 M | 1.06 M | 2 M | 1.02 M | 856 K | 3.49 M | 660 K | 430 K | 3.3 M | 3.29 M | 4.33 M | 4.33 M | 4.46 M | 182 K | 4.16 M | 4.16 M | 6.76 M | 5.81 M | 575 K | 575 K | 3.05 M | 10.8 M | 7.57 M | 7.57 M | 7.36 M | 6.48 M | 2.16 M | 2.16 M | 2.92 M | 2.94 M | 7.12 M | 7.12 M | 8.84 M |
Book Value |
-332 K | -1.9 M | 93 K | 1.9 M | 4.64 M | 9.24 M | 9.17 M | 8.98 M | 9.1 M | 8.09 M | 8.07 M | 7.54 M | 7.43 M | 3.18 M | 6.89 M | 5.51 M | 5.1 M | 2.32 M | 2.11 M | 1.73 M | 2.24 M | 472 K | 1.99 M | 602 K | 3 K | 2.04 M | 373 K | 290 K | 400 K | 2.26 M | 3.2 M | 3.18 M | 238 K | -4.14 M | 4.1 M | 5.9 M | 8.06 M | 4.49 M | -1.86 M | 439 K | 3.2 M | 9.34 M | 4.14 M | 5.99 M | 7.68 M | 4.78 M | 975 K | 2.32 M | 2.88 M | - | 5.77 M | 7.17 M | 8.18 M |
Total Shareholders Equity |
-332 K | -1.9 M | 93 K | 1.9 M | 4.64 M | 9.24 M | 9.17 M | 8.98 M | 9.1 M | 8.09 M | 8.07 M | 7.54 M | 7.54 M | 5.51 M | 6.89 M | 6.89 M | 5.51 M | 2.32 M | 2.11 M | 2.11 M | 1.73 M | 472 K | 1.99 M | 1.99 M | 602 K | 2.04 M | 373 K | 290 K | 400 K | 2.26 M | 3.2 M | 3.18 M | 238 K | -4.14 M | 4.1 M | 5.9 M | 8.06 M | 4.49 M | -1.86 M | 439 K | 3.2 M | -7.6 M | -12.7 M | -10.9 M | -9.21 M | -3.38 M | -7.18 M | -5.84 M | -5.28 M | - | -2.39 M | -992 K | 19 K |
All numbers in USD currency